4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-, hydrochloride (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

ML 315 Hydrochloride is an inhibitor of Clk and DYRK kinases which may be applied to the treatment of disorders resulting from erroneous mRNA splicing.

4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-, hydrochloride (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-, hydrochloride (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shanghai Beckham Medical Technology Co., Ltd	021-13816613772 13816613772	huahero21@sina.com	China	568	55
Shanghai SuperLan Chemcial Technique Centre	021-2022843681 15618226720	lucy@atkchemical.com	China	9952	58
Jinan Jiuli Biotechnology Co. , Ltd.	15865264761	486064515@qq.com	China	4542	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	19704	58

---

• 4-Pyrimidinamine, 5-(1,3-benzodioxol-5-yl)-N-[(3,5-dichlorophenyl)methyl]-, hydrochloride (1:1)
• ML315 HCl
• 2172559-91-8